Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

3.83
-0.0900-2.30%
Post-market: 3.830.00000.00%16:10 EDT
Volume:6.93K
Turnover:27.01K
Market Cap:4.38M
PE:-0.19
High:4.09
Open:3.99
Low:3.80
Close:3.92
52wk High:63.20
52wk Low:3.25
Shares:1.14M
Float Shares:863.27K
Volume Ratio:0.09
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.5537
EPS(LYR):-20.5537
ROE:-68.43%
ROA:-15.36%
PB:0.15
PE(LYR):-0.19

Loading ...

BRIEF-Akari Therapeutics Announces $5 Million Financing

Reuters
·
Dec 16, 2025

Press Release: Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market

Dow Jones
·
Dec 16, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week

MT Newswires Live
·
Dec 13, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Dec 12, 2025

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading

MT Newswires Live
·
Dec 11, 2025

BRIEF-Akari Therapeutics Announces Preclinical Data On AKTX-101 For Pancreatic Cancer

Reuters
·
Dec 09, 2025

Akari Therapeutics Plc - Announces Preclinical Data on Aktx-101 for Pancreatic Cancer

THOMSON REUTERS
·
Dec 09, 2025

Akari Therapeutics Plc - Plans First-in-Human Trial for Aktx-101 in Late 2026

THOMSON REUTERS
·
Dec 09, 2025

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

GlobeNewswire
·
Dec 09, 2025

European Equities Traded in the US as ADRs Little Changed in Monday Trading

MT Newswires Live
·
Dec 09, 2025

BRIEF-Akari Therapeutics Provides Corporate Update

Reuters
·
Dec 04, 2025

Press Release: Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment

Dow Jones
·
Dec 04, 2025

ADRs End Lower; Akari Therapeutics PLC Declines 17%

Dow Jones
·
Dec 02, 2025

Akari Therapeutics Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Reuters
·
Nov 27, 2025

European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
Nov 27, 2025

European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading

MT Newswires Live
·
Nov 25, 2025

Analysts’ Top Healthcare Picks: Qiagen (QGEN), Akari Therapeutics (AKTX)

TIPRANKS
·
Nov 20, 2025

BRIEF-Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag As Interim Chief Financial Officer

Reuters
·
Nov 18, 2025

Press Release: Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer

Dow Jones
·
Nov 18, 2025

European Equities Traded in the US as American Depositary Receipts Slightly Lower in Monday Trading

MT Newswires Live
·
Nov 18, 2025